Nitric oxide in the cardiovascular system

Coronary Artery Disease

Volumn 10, Issue 5, 1999, Pages 273-276

  Stamler, Jonathan S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; Blood flow; Blood pressure; Cardiovascular; Heart; Nitric oxide; Platelets; Respiration

Indexed keywords

ENDOTHELIUM DERIVED RELAXING FACTOR; ICOSANOID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ARTERY DISEASE; ATHEROSCLEROSIS; BLOOD FLOW; BLOOD PRESSURE REGULATION; BREATHING PATTERN; CARDIOVASCULAR SYSTEM; DIABETES MELLITUS; EXERCISE; HEART FAILURE; HEART FUNCTION; HEART TRANSPLANTATION; OXYGEN CONSUMPTION; PHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESTENOSIS; SHORT SURVEY; THROMBOSIS;

EID: 0032772661     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199907000-00001     Document Type: Short Survey

References (57)

1. 1 Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43:109-142.
2. 2 Ignarro LJ. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol 1990; 30:535-560.
3. 3 Nathan C, Xie QW. Nitric oxide syntheses: roles, tolls, and controls. Cell 1994; 78:915-918.
4. 4 Sasa Kam T. Expression and regulation of endothelial nitric oxide synthase. Trends Cardiovasc Med 1997; 7:28-37.
5. 5 Stamler JS. Alzheimer's disease: a radical vascular connection. Nature 1996; 380:108-111.
6. 6 Lancaster JR Jr. Stimulation of the diffusion and reaction of endogenously produced nitric oxide. Proc Natl Acad Sci USA 1994; 91:8137-8141.
7. 7 Stamler JS, Toone EJ, Lipton SA, Sucher NJ. (S)NO signals: translocation, regulation, and a consensus motif. Neuron 1997; 18:691-696.
8. 8 Kelly RA, Balligand JL, Smith TW. Nitric oxide and cardiac function. Circ Res 1996; 79:363-380.
9. 9 Miles PR, Bowman L, Rengasamy A, Huffman L. Constitutive nitric oxide production by rat alveolar macrophages. Am J Physiol 1998; 274:L360-L368.
10. 10 Burnett AL, Nelson RJ, Calvin DC, Liu JX, Demas GE, Klein SL, et al. Nitric oxide-dependent penile erection in mice lacking neuronal nitric oxide synthase. Mol Med 1996; 2:288-296.
11. 11 Le Cras TD, Tyler RC, Horan MP, Morris KG, Tuder RM, McMurtry IF, et al. Effects of chronic hypoxia and altered hemodynamics on endothelial nitric oxide synthase expression in the adult rat lung. J Clin Invest 1998; 101:795-801.
12. 12 Oemar BS, Tschudi MR, Godoy N, Brovkovich V, Malinski T, Luscher TF. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation 1998; 97:2494-2498.
13. 13 Clyman RI, Waleh N, Black SM, Riemer RK, Mauray F, Chen YQ. Regulation of ductus arteriosus patency by nitric oxide in fetal lambs: the role of gestation, oxygen tension, and vasa vasorum. Pediatr Res 1998; 43:633-644.
14. 14 Ursell PC, Mayes M. Enothelial isoform of nitric oxide synthase in rat heart increases during development. Anat Rec 1996; 246:465-472.
15. 15 Pham SM, Shears LL, Kawaharada N, Li S, Venkataramanan R, Sehgal S. High local production of nitric oxide as a possible mechanism by which rapamycin prevents transplant arteriosclerosis. Transplant Proc 1998; 30:953-954.
16. 16 Haywood GA, Tsao PS, von der Leyen HE, Mann MJ, Keeling PJ, Trindade PT, et al. Expression of inducible nitric oxide synthase in human heart failure. Circulation 1996; 93:1087-1094.
17. 17 Zheng Z, Shimamura K, Anthony TL, Travagli RA, Kreulen DL. Nitric oxide is a sensory nerve neurotransmitter in the mesenteric artery of guinea pig. J Auton Nerv Syst 1997; 67:137-144.
18. 18 Silvagno F, Xia H, Bredt DS. Neuronal nitric-oxide synthase-mu, an alternatively spliced isoform expressed in differentiated skeletal muscle. J Biol Chem 1996; 271:11204-11208.
19. 19 Wilcox JN, Subramanian RR, Sundell CL, Tracey WR, Pollock JS, Harrison DG, et al. Expression of multiple nitric oxide synthase isoforms in normal and atherosclerotic vessels. Arterioscler Thromb Vasc Biol 1997; 17:2479-2488.
20. 20 Stamler JS. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 1994; 78:931-936.
21. 21 Brunner F, Schmidt K, Nielsen EB, Mayer B. Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery. J Phar Exp Therapeutics 1996; 277:48-53.
22. 22 Brunner F, Stessel H, Kukovetz WR. Novel guanylyl cyclase inhibitor, ODQ reveals role of nitric oxide, but not of cyclic GMP in endothelin-1 secretion. FEBS Lett 1995; 376:262-266.
23. 23 Xu L, Eu JP, Meissner G, Stamler JS. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 1998; 279:234-237.
24. 24 Myatt L, Brewer AS, Langdon G, Brockman DE. Attenuation of the vasoconstrictor effects of thromboxane and endothelin by nitric oxide in the human fetal-placental circulation. Am J Obstet Gynecol 1992; 166:224-230.
25. 25 North AJ, Star RA, Brannon TS, Ujiie K, Wells LB, Lowenstein CJ, et al. Nitric oxide synthase type I and type III gene expression are developmental regulated in rat lung. Am J Physiol 1994; 266:L636-L641.
26. 26 Stamler JS, Loh E, Roddy MA, Currie KE, Creager MA. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 1994; 89:2035-2040.
27. 27 Blitzer ML, Loh E, Roddy MA, Stamler JS, Creager MA. Endothelium-derived nitric oxide regulates systemic and pulmonary vascular resistance during acute hypoxia in humans. J Am Coll Cardiol 1996; 28:591-596.
28. 28 Park KH, Rubin LE, Gross SS, Levi R. Nitric oxide is a mediator of hypoxic coronary vasodilatation. Relation to adenosine and cyclooxygenase-derived metabolites. Circ Res 1992; 71:992-1001.
29. 29 Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 1998; 101:2567-2578.
30. 30 Vita JA, Frei B, Holbrook M, Gokce N, Leaf C, Keany JFJ. L-2-Oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease. J Clin Invest 1998; 101:1408-1414.
31. 31 Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990; 81:491-497.
32. 32 Katz SD, Schwarz M, Yuen J, LeJemtel TH. Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Circulation 1993; 88:55-61.
33. 33 Li Z, Chapleau MW, Bates JN, Bielefeldt K, Lee HC, Abboud FM. Nitric oxide as an autocrine regulator of sodium currents in baroreceptor neurons. Neuron 1998; 20:1039-1049.
34. 34 Ohta H, Bates JN, Lewis SJ, Talman WT. Actions of S-nitrosocysteine in the nucleus tractus solitarii are unrelated to release of nitric oxide. Brain Res 1997; 746:98-104.
35. 35 Murakami H, Liu JL, Yoneyama H, Nishida Y, Okada K, Kosaka H, et al. Blockade of neuronal nitric oxide synthase alters the baroreflex control of heart rate in the rabbit. Am J Physiol 1998; 274:R181-R186.
36. 36 Panza JA, Casino PR, Badar DM, Quyyumi AA. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation 1993; 87:1475-1481.
37. 37 MacDonald PS, Read MA, Dusting GJ. Synergistic inhibition of platelet aggregation by endothelium-derived relaxing factor and prostacyclin. Thromb Res 1988; 49:437-439.
38. 38 Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329:2002-2012.
39. 39 Stamler JS, Simon DI, Jaraki O, Osborne JA, Francis S, Mullins M, et al. S-nitrosylation of tissue-type plasminogen activator confers vasodilatory and antiplatelet properties on the enzyme. Proc Natl Acad Sci USA 1992; 89:8087-8091.
40. 1, and nitroglycerin. Circ Res 1989; 65:796-804.
41. 41 Yan ZQ, Yokota T, Zhang W, Hansson GK. Expression of inducible nitric oxide synthase inhibits platelet adhesion and restores blood flow in the injured artery. Circ Res 1996; 79:38-44.
42. 42 Sarkar R, Webb RC. Does nitric oxide regulate smooth muscle cell proliferation? A critical appraisal. J Vasc Res 1998; 35:135-142.
43. 43 Dinh-Xuan AT, Higgenbottam TW, Clelland CA, Pepke-Zaba J, Cremona G, Butt AY. Impairment of endothelium-dependent pulmonary artery relaxation in chronic obstructive lung disease. N Engl J Med 1991; 324:1539-1547.
44. 44 Kinsella JP, Neish SR, Shaffer E, Abman SH. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340:819-820.
45. 45 Lieberman EH, Gerhard MD, Uehata A, Walsh BW, Selwyn AP, Ganz P. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med 1994; 121:936-941.
46. 46 Clarkson P, Adams MR, Powe AJ, Donald AE, McCredie R, Robinson J. Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. J Clin Invest 1996; 97:1989-1994.
47. 47 Pinsky DJ, Patton S, Mesaros S, Brovkovych V, Kubaszewski E, Grunfeld S, et al. Mechanical transduction of nitric oxide synthesis in the beating heart. Circ Res 1997; 81:372-379.
48. 48 Paulus WJ, Vantrimpont PJ, Shah AM. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion. Circulation 1994; 89:2070-2078.
49. 49 Kojda G, Kottenberg K, Stasch JP, Schror K, Noack E. Positive inotropic effect of exogenous and endogenous NO in hypertrophic rat hearts. Br J Pharmacol 1997; 122:813-820.
50. 50 Musialek P, Lei M, Brown HF, Paterson DJ, Casadei B. Nitric oxide can increase heart rate by stimulating the hyperpolarization-activated inward current, I(f). Circ Res 1997; 81:60-68.
51. 51 Jumrussirikul P, Dinerman J, Dawson TM, Dawson VL, Ekelund U, Georgakopoulos D, et al. Interaction between neuronal nitric oxide synthase and inhibitory G protein activity in heart rate regulation in conscious mice. J Clin Invest 1998; 102:1279-1285.
52. 52 Pabla R, Curtis MJ. Effects of NO modulation on cardiac arrhythmias in the rat isolated heart. Circ Res 1995; 77:984-992.
53. 53 Stamler JS, Jia L, Eu JP, McMahon TJ, Demchenko IT, Bonaventura J, et al. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science 1997; 276:2034-2037.
54. 54 Funai EF, Davidson A, Seligman SP, Finlay TH. S-nitrosohemoglobin in the fetal circulation may represent a cycle for blood pressure regulation. Biochem Biophys Res Commun 1997; 239:875-877.
55. 55 Pawloski JR, Swaminathan RV, Stamler JS. Cell-free and erythrocytic S-nitrosohemoglobin inhibits human platelet aggregation. Circulation 1998; 97:263-267.
56. 56 Butler AR, Rhodes P. Chemistry, analysis, and biological roles of S-nitrosothiols. Anal Biochem 1997; 249:1-9.
57. 57 Jia L, Bonaventura C, Bonaventura J, Stamler JS. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 1996; 380:221-226.